These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25380501)

  • 1. Modulation of non steroidal anti-inflammatory drug induced membrane fusion by copper coordination of these drugs: anchoring effect.
    Majumdar A; Chakraborty S; Sarkar M
    J Phys Chem B; 2014 Dec; 118(48):13785-99. PubMed ID: 25380501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lipid molecule headgroup mismatch on non steroidal anti-inflammatory drugs induced membrane fusion.
    Mondal Roy S; Sarkar M
    Langmuir; 2011 Dec; 27(24):15054-64. PubMed ID: 21999838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-steroidal anti-inflammatory drug induced membrane fusion: concentration and temperature effects.
    Mondal S; Sarkar M
    J Phys Chem B; 2009 Dec; 113(51):16323-31. PubMed ID: 19954169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Mismatches in Fatty Acyl Tail Lengths Can Effect Non Steroidal Anti-Inflammatory Drug Induced Membrane Fusion.
    Majumdar A; Sarkar M
    J Phys Chem B; 2016 Jun; 120(21):4791-802. PubMed ID: 27153337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of increase in orientational order of lipid chains and head group spacing on non steroidal anti-inflammatory drug induced membrane fusion.
    Roy SM; Bansode AS; Sarkar M
    Langmuir; 2010 Dec; 26(24):18967-75. PubMed ID: 21114267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct binding of Cu(II)-complexes of oxicam NSAIDs with DNA backbone.
    Roy S; Banerjee R; Sarkar M
    J Inorg Biochem; 2006 Aug; 100(8):1320-31. PubMed ID: 16684565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of oxicam NSAIDs with DMPC vesicles: differential partitioning of drugs.
    Chakraborty H; Roy S; Sarkar M
    Chem Phys Lipids; 2005 Dec; 138(1-2):20-8. PubMed ID: 16183046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane fusion: a new function of non steroidal anti-inflammatory drugs.
    Chakraborty H; Mondal S; Sarkar M
    Biophys Chem; 2008 Sep; 137(1):28-34. PubMed ID: 18617319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectroscopic studies of the binding of Cu(II) complexes of oxicam NSAIDs to alternating G-C and homopolymeric G-C sequences.
    Chakraborty S; Bose M; Sarkar M
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():690-7. PubMed ID: 24345609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Effect of Oxicam Non-Steroidal Anti-Inflammatory Drugs on Membranes and Their Consequence on Membrane Fusion.
    Majumdar A; Kundu D; Sarkar M
    J Phys Chem B; 2015 Jul; 119(30):9627-39. PubMed ID: 26147344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of Cu(II) complexes of oxicam NSAIDs to alternating AT and homopolymeric AT sequences: differential response to variation in backbone structure.
    Chakraborty S; Sehanobish E; Sarkar M
    J Biol Inorg Chem; 2012 Mar; 17(3):475-87. PubMed ID: 22270943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of piroxicam and meloxicam with DMPG/DMPC mixed vesicles: anomalous partitioning behavior.
    Chakraborty H; Sarkar M
    Biophys Chem; 2007 Feb; 125(2-3):306-13. PubMed ID: 17010502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of non-steroid anti-inflammatory drugs in membrane bilayers.
    Kyrikou I; Hadjikakou SK; Kovala-Demertzi D; Viras K; Mavromoustakos T
    Chem Phys Lipids; 2004 Dec; 132(2):157-69. PubMed ID: 15555602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photophysical studies of oxicam group of NSAIDs: piroxicam, meloxicam and tenoxicam.
    Banerjee R; Chakraborty H; Sarkar M
    Spectrochim Acta A Mol Biomol Spectrosc; 2003 Apr; 59(6):1213-22. PubMed ID: 12659890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual coordinating behavior by three non-steroidal anti-inflammatory drugs from the oxicam family towards copper(II). Synthesis, X-ray structure for copper(II)-isoxicam, -meloxicam and -cinnoxicam-derivative complexes, and cytotoxic activity for a copper(II)-piroxicam complex.
    Cini R; Tamasi G; Defazio S; Hursthouse MB
    J Inorg Biochem; 2007 Aug; 101(8):1140-52. PubMed ID: 17592742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of new oxicam derivatives with lipid bilayers as measured by calorimetry and fluorescence spectroscopy.
    Maniewska J; Gąsiorowska J; Szczęśniak-Sięga B; Michalak K
    Acta Biochim Pol; 2018; 65(2):185-191. PubMed ID: 29796443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of Oxicam NSAIDs with lipid monolayer: anomalous dependence on drug concentration.
    Kundu S; Chakraborty H; Sarkar M; Datta A
    Colloids Surf B Biointerfaces; 2009 Apr; 70(1):157-61. PubMed ID: 19157803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semi solid matrix formulations of meloxicam and tenoxicam: an in vitro and in vivo evaluation.
    Alladi S; Shastri NR
    Arch Pharm Res; 2015; 38(5):801-12. PubMed ID: 24752862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network.
    Xu S; Hermanson DJ; Banerjee S; Ghebreselasie K; Clayton GM; Garavito RM; Marnett LJ
    J Biol Chem; 2014 Mar; 289(10):6799-6808. PubMed ID: 24425867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of NSAIDs in micelles: implication of structural switchover in drug-membrane interaction.
    Chakraborty H; Banerjee R; Sarkar M
    Biophys Chem; 2003 May; 104(1):315-25. PubMed ID: 12834850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.